PENNUTO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.647
EU - Europa 514
AS - Asia 362
SA - Sud America 2
OC - Oceania 1
Totale 5.526
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.643
IT - Italia 306
CN - Cina 275
VN - Vietnam 61
FI - Finlandia 48
GB - Regno Unito 42
DE - Germania 33
SE - Svezia 23
HK - Hong Kong 17
UA - Ucraina 12
FR - Francia 10
IE - Irlanda 10
LU - Lussemburgo 9
BE - Belgio 5
CA - Canada 4
IN - India 4
NL - Olanda 4
KR - Corea 3
GR - Grecia 2
PL - Polonia 2
RU - Federazione Russa 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
NO - Norvegia 1
PT - Portogallo 1
SG - Singapore 1
TR - Turchia 1
Totale 5.526
Salva come PNG Salva come JPEG
Città #
Fairfield 1.079
Ashburn 461
Woodbridge 438
Houston 371
Seattle 368
Cambridge 346
Wilmington 279
Chandler 269
Ann Arbor 215
Padova 115
San Diego 115
Beijing 94
Princeton 79
Medford 75
Dong Ket 61
Des Moines 48
Roxbury 46
New York 38
Helsinki 34
Nanjing 31
Milan 20
London 15
Jinan 13
Nanchang 12
Boardman 11
Guangzhou 11
Hebei 11
Hong Kong 11
Jacksonville 11
Kilburn 11
Shenyang 11
Washington 10
Dublin 9
Kharkiv 9
Aprilia 8
Hesperange 8
Phoenix 8
Rome 8
Trento 8
Jiaxing 7
Treviso 7
Paris 6
Zhengzhou 5
Haikou 4
Hounslow 4
Karlsruhe 4
Kunming 4
Lappeenranta 4
Ningbo 4
Tianjin 4
Turin 4
Venice 4
Vicenza 4
Balestrino 3
Brussels 3
Changsha 3
Chicago 3
Cumming 3
Florence 3
Gelsenkirchen 3
Hangzhou 3
Inzago 3
Legnago 3
Magenta 3
Montegrosso d'Asti 3
Montréal 3
Pune 3
Selvazzano Dentro 3
Shanghai 3
St Louis 3
Borås 2
Busto Arsizio 2
Este 2
Fort Worth 2
Gdansk 2
Honolulu 2
Kraainem 2
Lanzhou 2
Los Angeles 2
Menlo Park 2
Naples 2
Ogden 2
Paullo 2
Piove Di Sacco 2
Rimini 2
Rovereto 2
Taiyuan 2
Thiene 2
Vedano Olona 2
Verona 2
Acton 1
Adelaide 1
Athens 1
Bagnaria Arsa 1
Barrafranca 1
Berlin 1
Biancavilla 1
Brendola 1
Buia 1
Bupyeong-gu 1
Totale 4.933
Salva come PNG Salva come JPEG
Nome #
Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet 184
Non-neural phenotype of spinal and bulbar muscular atrophy: Results from a large cohort of Italian patients 177
Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet 157
Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients 151
Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy 132
210th ENMC International Workshop: Research and clinical management of patients with spinal and bulbar muscular atrophy, 27-29 March, 2015, Naarden, The Netherlands 131
Pathogenesis of Polyglutamine Diseases 111
Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism 109
Protein Arginine Methyltransferase 6 Enhances Polyglutamine-Expanded Androgen Receptor Function and Toxicity in Spinal and Bulbar Muscular Atrophy 107
Aberrant Autophagic Response in The Muscle of A Knock-in Mouse Model of Spinal and Bulbar Muscular Atrophy 101
Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy. 97
CAG repeat length in androgen receptor gene is not associated with amyotrophic lateral sclerosis. 93
Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity 93
The role of AR polyQ tract in male breast carcinoma: lesson from an SBMA case 92
Insights into the genetic epidemiology of SBMA: prevalence estimation and multiple founder haplotypes in the Veneto Italian region. 90
Beyond motor neurons: expanding the clinical spectrum in Kennedy's disease 89
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 88
Taipoxin induces synaptic vesicle exocytosis and disrupts the interaction of synaptophysin I with VAMP2 86
B2 attenuates polyglutamine-expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy 85
Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice 83
Neurotoxic effects of androgens in spinal and bulbar muscular atrophy 81
No effect of AR polyG polymorphism on spinal and bulbar muscular atrophy phenotype 80
Androgens affect muscle, motor neuron, and survival in a mouse model of SOD1-related amyotrophic lateral sclerosis 78
Autophagic and Proteasomal Mediated Removal of Mutant Androgen Receptor in Muscle Models of Spinal and Bulbar Muscular Atrophy 76
Snake presynaptic neurotoxins with phospholipase A2 activity induce swelling of synaptic boutons and exoxytosis of synaptic vesicles 75
Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice 73
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 73
Altered ionic currents and amelioration by IGF-1 and PACAP in motoneuron-derived cells modelling SBMA 73
Synaptophysin: Leading actor or walk-on role in synaptic vesicle exocytosis? 72
Calcium signalling-dependent mitochondrial dysfunction and bioenergetics regulation in respiratory chain Complex II deficiency 70
Post-translational modifications of expanded polyglutamine proteins: Impact on neurotoxicity 69
Fluorescence resonance energy transfer detection of synaptophysin I and vesicle-associated membrane protein 2 interactions during exocytosis from single live synapses 67
Interplay of the E box, the cyclic AMP response element, and HTF4/HEB in transcriptional regulation of the neurospecific, neurotrophin-inducible vgf gene 67
Synaptophysin I Controls the Targeting of VAMP2/Synaptobrevin II to Synaptic Vesicles 67
Catechol-O-methyl transferase modulates cognition in late life: Evidence and implications for cognitive enhancement 67
NURR1 and ERR1 modulate the expression of genes of a DRD2 co-expression network enriched for schizophrenia risk 67
Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes 65
Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization 65
Insulin-like growth factor 1 signaling in motor neuron and polyglutamine diseases: From molecular pathogenesis to therapeutic perspectives 62
Huntingtin-mediated axonal transport requires arginine methylation by PRMT6 62
Motor Neuron Diseases and Neuroprotective Peptides: A Closer Look to Neurons 62
From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet? 61
Mutations in TGM6 induce the unfolded protein response in SCA35 60
Mitochondrial implications in bulbospinal muscular atrophy (Kennedy disease) 60
Neurite extension occurs in the absence of regulated exocytosis in PC12 subclones 59
Differential autophagy power in the spinal cord and muscle of transgenic ALS mice 59
Protein Arginine Methyltransferase 1 and 8 Interact with FUS to Modify Its Sub-Cellular Distribution and Toxicity In Vitro and In Vivo 58
Rescue of Metabolic Alterations in AR113Q Skeletal Muscle by Peripheral Androgen Receptor Gene Silencing 57
The E3 ubiquitin ligase TRIM11 mediates the degradation of congenital central hypoventilation syndrome-associated polyalanine-expanded PHOX2B 57
The E3 ubiquitin-protein ligase MDM2 is a novel interactor of the von Hippel-Lindau tumor suppressor 57
New routes to therapy for spinal and bulbar muscular atrophy 55
Cell-autonomous and non-cell-autonomous toxicity in polyglutamine diseases 55
Identification and Expression of Acetylcholinesterase in Octopus vulgaris Arm Development and Regeneration: a Conserved Role for ACHE? 55
Revisiting default mode network function in major depression: Evidence for disrupted subsystem connectivity 55
Mitochondrial abnormalities in spinal and bulbar muscular atrophy 54
In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy 54
Transforming growth factor beta 1 signaling is altered in the spinal cord and muscle of amyotrophic lateral sclerosis mice and patients 53
Serine phosphorylation and arginine methylation at the crossroads to neurodegeneration 52
Overexpression of IGF-1 in Muscle Attenuates Disease in a Mouse Model of Spinal and Bulbar Muscular Atrophy 52
MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B 51
241st ENMC international workshop: Towards a European unifying lab for Kennedy's disease. 15-17th February, 2019 Hoofddorp, The Netherlands 51
MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease 50
Post-translational modifications and protein quality control in motor neuron and polyglutamine diseases 50
Introduction to the Special Issue on Spinal and Bulbar Muscular Atrophy 48
Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis 48
Native functions of the androgen receptor are essential to pathogenesis in a drosophila model of spinobulbar muscular atrophy 46
Increased transcription of transglutaminase 1 mediates neuronal death in in vitro models of neuronal stress and Aβ1–42-mediated toxicity 46
Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA) 46
Pituitary Adenylyl Cyclase Activating Polypeptide (PACAP) Signaling and the Cell Cycle Machinery in Neurodegenerative Diseases 44
The pVHL neglected functions, a tale of hypoxia-dependent and -independent regulations in cancer 43
Clenbuterol-sensitive delayed outward potassium currents in a cell model of spinal and bulbar muscular atrophy 38
ClC-2-like Chloride Current Alterations in a Cell Model of Spinal and Bulbar Muscular Atrophy, a Polyglutamine Disease 35
Pharmacological inactivation of the prion protein by targeting a folding intermediate 33
Defective excitation-contraction coupling and mitochondrial respiration precede mitochondrial Ca2+ accumulation in spinobulbar muscular atrophy skeletal muscle 31
Antagonistic effect of cyclin-dependent kinases and a calcium-dependent phosphatase on polyglutamine-expanded androgen receptor toxic gain of function 30
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice 26
Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity 26
Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy 25
NGF-dependent and tissue-specific transcription of vgf is regulated by a CREB-p300 and bHLH factor interaction 25
AR cooperates with SMAD4 to maintain skeletal muscle homeostasis 25
Bicalutamide and Trehalose Ameliorate Spinal and Bulbar Muscular Atrophy Pathology in Mice 22
Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome 16
Mutational screening of androgen receptor gene in 8224 men of infertile couples 15
Editorial Comment to Castration-resistant prostate cancer diagnosed during leuprorelin treatment for spinal and bulbar muscular atrophy 15
Skeletal Muscle Pathogenesis in Polyglutamine Diseases 14
Induced pluripotent stem cells for modeling Smith-Magenis syndrome 13
Introduction to the Special Issue “Skeletal Muscle Atrophy: Mechanisms at a Cellular Level” 9
The value of serum creatinine as biomarker of disease progression in spinal and bulbar muscular atrophy (SBMA) 4
Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle 1
Increased SIRT3 combined with PARP inhibition rescues motor function of SBMA mice 1
Totale 5.667
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.790
article - articoli 22.532
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 258
Totale 45.580
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019465 0 0 0 0 0 0 0 0 0 94 206 165
2019/20201.329 131 67 30 120 137 88 136 156 180 156 79 49
2020/20211.034 56 67 42 71 85 33 25 93 133 163 127 139
2021/20221.302 47 195 222 69 37 61 88 112 54 40 135 242
2022/2023684 121 75 12 66 100 75 10 89 82 5 31 18
2023/2024554 24 50 72 58 81 118 77 30 29 15 0 0
Totale 5.667